Market: NASD |
Currency: USD
Address: 455 North Bernardo Avenue
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Show more
📈 NeuroPace, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$16.75
-
Upside/Downside from Analyst Target:
83.06%
-
Broker Call:
16
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
10-25%
-
Net Income Growth Range (1Y):
10-25%
-
Revenue Growth Range (1Y):
10-25%
-
Upcoming Earnings Date:
2025-11-12
-
EPS Estimate:
-0.19
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for NeuroPace, Inc.
Date | Reported EPS |
---|
2025-11-11 (estimated upcoming) | - |
2025-08-12 | -0.26 |
2025-05-13 | -0.21 |
2025-03-04 | -0.18 |
2024-11-12 | -0.19 |
2024-08-13 | -0.26 |
2024-05-08 | -0.32 |
2024-03-05 | -0.23 |
2023-11-06 | -0.28 |
2023-08-08 | -0.36 |
2023-05-04 | -0.41 |
2023-03-02 | -0.45 |
2022-11-08 | -0.48 |
2022-08-11 | -0.52 |
2022-05-12 | -0.47 |
2022-03-10 | -0.44 |
2021-11-10 | -0.34 |
2021-08-12 | -0.48 |
2021-06-03 | -0.36 |
📰 Related News & Research
No related articles found for "neuropace inc".